Canada-based biotechnology company Kane Biotech announced that DispersinB-Gentamicin combination wound gel spray has passed the primary skin irritation tests. The test was aimed at determining the dermal irritation potential of the spray ...
Tags: Dispersinb Combination, Skin Irritation Tests, Medicine